Androgen receptor pathway in rats with autosomal dominant polycystic kidney disease.

Androgens have been implicated in mediating disease escalation in autosomal dominant polycystic kidney disease (ADPKD). Dihydrotestosterone (DHT), an agonist, and flutamide (FLT), an antagonist, were administered to Han:SPRD rats with ADPKD, and the role of androgen receptor (AR) abundance and activation on the enlargement and function of cystic kidneys was evaluated. Renal AR abundance determined by immunoblots in 8- to 10-wk-old Cy/+ male rats was naturally increased four-fold above that of littermate +/+ controls. In male Cy/+, castration decreased AR abundance below control +/+ by -89.4%, and AR expression within cyst mural epithelial cells was strikingly decreased. Castration of Cy/+ male rats also reduced the usual increases in kidney weight by -49.7%, kidney cyst area by -34.0%, and serum urea nitrogen by -72.8%; these indices were restored to precastration levels by DHT. In Cy/+ male rats, FLT administration reduced the increase in kidney weight by -27.6% and serum urea nitrogen by -53.7% and decreased the increment in AR expression by -84.2% in comparison with untreated +/+ controls. There was no effect of FLT in female rats. Immunoblot expression of phospho-extracellular signal-regulated kinase 1/2 (P-ERK) and B-Raf, key intermediates in the mitogen-activated protein kinase pathway that are abnormally elevated in Cy/+, was unaffected by castration and/or administration of DHT or FLT. AR was not expressed in renal epithelial cell nuclei of androgen-deficient rats but was displayed in most tubule and mural cyst cell nuclei of androgen-replete rats. In androgen-deficient Cy/+, 80.6% of renal epithelial cells that had entered the cell cycle (proliferating cell nuclear antigen positive) also expressed P-ERK. In androgen-replete rats, proliferating cell nuclear antigen-positive cells co-expressed AR (12.7%), P-ERK (36.4%), and P-ERK + AR (45.0%); 5.9% were probably stimulated by other mitogenic mechanisms. It is concluded that androgens potentiate renal cell proliferation and cyst enlargement through ERK1/2-dependent and ERK1/2-independent signaling mechanisms in Han:SPRD. It is suggested that the basal rate of cell proliferation is determined by ERK1/2 signaling to a major extent and that androgens have additive effects.

[1]  James P Calvet,et al.  Calcium Restriction Allows cAMP Activation of the B-Raf/ERK Pathway, Switching Cells to a cAMP-dependent Growth-stimulated Phenotype* , 2004, Journal of Biological Chemistry.

[2]  D. Wallace,et al.  Cyclic AMP promotes growth and secretion in human polycystic kidney epithelial cells. , 2004, Kidney international.

[3]  N. Hollenberg Aldosterone in the development and progression of renal injury. , 2004, Kidney international.

[4]  S. Somlo,et al.  Effective treatment of an orthologous model of autosomal dominant polycystic kidney disease , 2004, Nature Medicine.

[5]  E. Avner,et al.  EGF receptor tyrosine kinase inhibition attenuates the development of PKD in Han:SPRD rats. , 2003, Kidney international.

[6]  J. Grantham,et al.  Lillian Jean Kaplan International Prize for advancement in the understanding of polycystic kidney disease. Understanding polycystic kidney disease: a systems biology approach. , 2003, Kidney international.

[7]  Vincent H Gattone,et al.  Inhibition of renal cystic disease development and progression by a vasopressin V2 receptor antagonist , 2003, Nature Medicine.

[8]  J. Pelling,et al.  Cyclic AMP activates B-Raf and ERK in cyst epithelial cells from autosomal-dominant polycystic kidneys. , 2003, Kidney international.

[9]  R. Maser,et al.  Renal activation of extracellular signal-regulated kinase in rats with autosomal-dominant polycystic kidney disease. , 2003, Kidney international.

[10]  E. Bamgboye Hemodialysis: management problems in developing countries, with Nigeria as a surrogate. , 2003, Kidney international. Supplement.

[11]  R. Iliescu,et al.  Abolition of hypertension-induced end-organ damage by androgen receptor blockade in transgenic rats harboring the mouse ren-2 gene. , 2002, Journal of the American Society of Nephrology : JASN.

[12]  James P Calvet,et al.  Polycystin-1 Activation of c-Jun N-terminal Kinase and AP-1 Is Mediated by Heterotrimeric G Proteins* , 2002, The Journal of Biological Chemistry.

[13]  J. Calvet,et al.  The genetics and physiology of polycystic kidney disease. , 2001, Seminars in nephrology.

[14]  G. Pelletier Localization of androgen and estrogen receptors in rat and primate tissues. , 2000, Histology and histopathology.

[15]  W. Guggino,et al.  cAMP regulates cell proliferation and cyst formation in autosomal polycystic kidney disease cells. , 2000, Journal of the American Society of Nephrology : JASN.

[16]  S. Nakai,et al.  Gender difference in the mean age at the induction of hemodialysis in patients with autosomal dominant polycystic kidney disease. , 2000, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[17]  C. Lynch,et al.  Dihydrotestosterone and estrogen regulation of rat brain androgen-receptor immunoreactivity , 2000, Physiology & Behavior.

[18]  I. D. Román,et al.  Effect of flutamide-induced androgen-receptor blockade on adenylate cyclase activation through G-protein coupled receptors in rat prostate. , 2000, Cellular signalling.

[19]  L P Sullivan,et al.  cAMP stimulates the in vitro proliferation of renal cyst epithelial cells by activating the extracellular signal-regulated kinase pathway. , 2000, Kidney international.

[20]  S. Silbiger,et al.  Effect of gender on the progression of nondiabetic renal disease: a meta-analysis. , 2000, Journal of the American Society of Nephrology : JASN.

[21]  T. Okamoto,et al.  The Polycystic Kidney Disease-1 Protein, Polycystin-1, Binds and Activates Heterotrimeric G-Proteinsin Vitro , 1998 .

[22]  William E Sweeney,et al.  Functional activity of epidermal growth factor receptors in autosomal recessive polycystic kidney disease. , 1998, American journal of physiology. Renal physiology.

[23]  N. Gretz,et al.  Increased epithelial cell proliferation and abnormal extracellular matrix in rat polycystic kidney disease. , 1998, Journal of the American Society of Nephrology : JASN.

[24]  J. Grantham,et al.  Mechanisms of progression in autosomal dominant polycystic kidney disease. , 1997, Kidney international. Supplement.

[25]  S. Sandhu,et al.  Effects of sex hormones on fluid and solute transport in Madin-Darby canine kidney cells. , 1997, Kidney international.

[26]  V. Gattone,et al.  Gender and the effect of gonadal hormones on the progression of inherited polycystic kidney disease in rats. , 1997, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[27]  X. Estivill,et al.  Linkage, clinical features, and prognosis of autosomal dominant polycystic kidney disease types 1 and 2. , 1996, Journal of the American Society of Nephrology : JASN.

[28]  A. Evan,et al.  Role of obstruction in autosomal dominant polycystic kidney disease in rats. , 1996, Kidney international.

[29]  Patricia A. Gabow,et al.  PKD2, a Gene for Polycystic Kidney Disease That Encodes an Integral Membrane Protein , 1996, Science.

[30]  K. Georgopoulos,et al.  A dominant mutation in the Ikaros gene leads to rapid development of leukemia and lymphoma , 1995, Cell.

[31]  P. Bork,et al.  Polycystic kidney disease: The complete structure of the PKD1 gene and its protein , 1995, Cell.

[32]  E. Avner,et al.  Tyrosine kinase activity of the EGF receptor in murine metanephric organ culture. , 1995, Kidney international.

[33]  E. Avner,et al.  Epidermal growth factor receptor expression is abnormal in murine polycystic kidney. , 1995, Kidney international.

[34]  J. Pestka,et al.  Role of gender and strain in vomitoxin-induced dysregulation of IgA production and IgA nephropathy in the mouse. , 1994, Journal of toxicology and environmental health.

[35]  J. Stewart End-stage renal failure appears earlier in men than in women with polycystic kidney disease. , 1994, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[36]  The European Polycystic Kidney Disease Consortium The polycystic kidney disease 1 gene encodes a 14 kb transcript and lies within a duplicated region on chromosome 16 , 1994, Cell.

[37]  J. Grantham 1992 Homer Smith Award. Fluid secretion, cellular proliferation, and the pathogenesis of renal epithelial cysts. , 1993, Journal of the American Society of Nephrology : JASN.

[38]  Ann M. Johnson,et al.  Renal structure and hypertension in autosomal dominant polycystic kidney disease. , 1990, Kidney international.

[39]  Sheldon S. Stoffer Williams Textbook of Endocrinology , 1987 .

[40]  The European Polycystic Kidney Disease Consortium The polycystic kidney disease 1 gene encodes a 14 kb transcript and lies within a duplicated region on chromosome 16 , 2004, Pediatric Nephrology.

[41]  K. Sandberg,et al.  Sex and the renin angiotensin system: implications for gender differences in the progression of kidney disease. , 2003, Advances in renal replacement therapy.

[42]  B. Palmer Sexual dysfunction in men and women with chronic kidney disease and end-stage kidney disease. , 2003, Advances in renal replacement therapy.

[43]  R. Maser,et al.  Developmental expression of urine concentration-associated genes and their altered expression in murine infantile-type polycystic kidney disease. , 1999, Developmental genetics.

[44]  T. Okamoto,et al.  The polycystic kidney disease-1 protein, polycystin-1, binds and activates heterotrimeric G-proteins in vitro. , 1998, Biochemical and biophysical research communications.